NEW YORK (GenomeWeb News) – Bruker today said that it has already received more than 100 systems orders associated with various global stimulus funding programs.

The firm said that all five of its operating divisions have received stimulus orders for instruments such as mass spectrometry, NMR, pre-clinical MRI, and X-ray. Bruker estimated the average selling prices of these orders were greater than $500,000 per system — and the total amount of stimulus orders it received in the second half of 2009 exceeded $70 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.

Aug
23
Sponsored by
Tecan

This webinar will discuss an automated, high-throughput method of generating high-quality antigens and antibodies.